Clinical trial

DC Vaccine Combined With CIK Cells in Patients With SCLC

NCT02688673

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2014-08-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2014-08-01Date precision: month

Registry last updated2016-02-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Small- Cell Lung Cancerunresolved

Interventions

adenovirus-transfected autologous DC vaccine plus CIK cellsBIOLOGICAL

Sponsors & collaborators

Affiliated Hospital to Academy of Military Medical Scienceslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02688673 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.